UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021245
Receipt number R000024469
Scientific Title A prospective cohort study of Spondyloarthritis in Japan.
Date of disclosure of the study information 2016/03/01
Last modified on 2016/02/26 18:38:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective cohort study of Spondyloarthritis in Japan.

Acronym

A prospective cohort study of Spondyloarhritis in Japan.

Scientific Title

A prospective cohort study of Spondyloarthritis in Japan.

Scientific Title:Acronym

A prospective cohort study of Spondyloarhritis in Japan.

Region

Japan


Condition

Condition

spondyloarthritis

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the proportion of spondyloarthritis patients in Japan.

Basic objectives2

Others

Basic objectives -Others

Prospective cohort study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

proportion and status of spondyloarthritis in each patient.

Key secondary outcomes

1. Patient profile
2. Outcome of SpA patient
3. Activity of SpA
4. Seviarity of SpA
5. Treatment of SpA
6. Complication


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1 Aged 18 years or older
2 Doctor definitive diagnosis of SpA using ASAS
criteria for axial or peripheral SpA.
3 Possible to answer the quetionnaire.
4 Providing the consent

Key exclusion criteria

SpA patients not to provide the consent.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hajime Sano

Organization

The Japan Spondyloarthritis Society
Hyogo College of Medicine

Division name

Div.of Rheumatology, Dept. of Internal medicine

Zip code


Address

1-1Mukogawa-cho,Nishinomiya-shi

TEL

0798-45-6591

Email

hsano@hyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kiyoshi Matsui

Organization

Hyogo College of Medicine

Division name

Div of Rheumatology, Dept of Internal Medicine

Zip code


Address

1-1Mukogawa-cho, Nishinomiya-shi

TEL

0798-45-6591

Homepage URL


Email

k-matsui@hyo-med.ac.jp


Sponsor or person

Institute

The Japan Spondyloarthritis Society
Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

The Japan Spondyloarthritis Society

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学、山形大学、順天堂大学順天堂越谷病院、聖路加国際病院、東邦大学大橋病院、慶應義塾大学
桑名市総合医療センター、松野リウマチ整形外科、行岡病院、大阪大学、倉敷成人病センター、長崎大学
近藤リウマチ整形外科クリニック 


Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2016 Year 01 Month 25 Day

Date of IRB


Anticipated trial start date

2016 Year 03 Month 01 Day

Last follow-up date

2019 Year 09 Month 30 Day

Date of closure to data entry

2020 Year 03 Month 31 Day

Date trial data considered complete

2020 Year 03 Month 31 Day

Date analysis concluded

2021 Year 03 Month 31 Day


Other

Other related information

Prospective cohort study


Management information

Registered date

2016 Year 02 Month 29 Day

Last modified on

2016 Year 02 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024469


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name